HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,073,615 | -80.5% | 12,610 | -81.0% | 0.05% | -81.9% |
| Q1 2023 | $5,501,220 | -27.5% | 66,480 | -31.1% | 0.27% | -31.8% |
| Q4 2022 | $7,584,220 | +0.1% | 96,430 | -5.8% | 0.40% | -6.2% |
| Q3 2022 | $7,576,000 | +40.0% | 102,340 | +23.2% | 0.42% | +45.5% |
| Q2 2022 | $5,413,000 | -42.7% | 83,050 | +0.9% | 0.29% | -23.3% |
| Q4 2019 | $9,455,000 | -34.7% | 82,292 | -28.3% | 0.38% | -36.0% |
| Q3 2019 | $14,487,000 | +4.9% | 114,850 | +0.1% | 0.59% | +11.5% |
| Q2 2019 | $13,808,000 | +21.7% | 114,740 | +1.2% | 0.53% | +9.5% |
| Q4 2018 | $11,347,000 | -39.0% | 113,412 | -30.1% | 0.48% | -9.4% |
| Q3 2018 | $18,587,000 | -8.5% | 162,222 | -28.4% | 0.53% | -14.7% |
| Q2 2018 | $20,322,000 | +18.5% | 226,602 | -3.3% | 0.63% | +15.3% |
| Q1 2018 | $17,145,000 | +62.7% | 234,356 | +29.1% | 0.54% | +71.8% |
| Q4 2017 | $10,541,000 | – | 181,495 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |